iPSC Technology | Nexel, Human iPSC Derived Cells Provider

- Discover your
  NEXT hiPSC-derived CELLs
  with iPSC Technology
- Discover our
  NEXT Cells-based assay
  with iPSC Technology
Active in discovery and development of
novel biotherapeutics
to conquer unmet medical needs and iPSC technology
Go To Products
Product and Service
Cardiosight®-S

The Cardiosight®-S is a highly pure and electrophysiologically active population of cells, suitable for all types of experiments in the field of cardiomyocytes. Our priority is to ensure researchers get a reliable product and accelerate the diverse projects they are working on.

2020-12-14

NeXST service

NEXEL provides its Cardiac Safety Service using its own Cardiosight-S, making costs and experimental designs much more flexible. Reach out to us now and make your drug cardio-safe!

2020-12-14
Please enter your password first.

Password

Close Confirm

EVENT

KSNS 40th workshop

NEXEL will attend The Korean Society of Non-Clinical Study 2021 to introduce our products and service to other participants and attendees. The theme of this 40th workshop is "Dynamically Growing K-Bio R&D in 2021". Come visit us at Booth #5 Date of Event: 2021. 12. 16

2021-11-23

AHA Scientific Session 2021

American Heart Association NEXEL will be virtually attending the Scientific Session 2021 to extend our knowledge regarding cardiovascular studies and potentially incorporate it into our pipelines. The AHA Scientific Session is the world's premier cardiovascular conference held annually by American Heart Association. AHA Scientific Session 2021 will be held as a hybrid event of virtual and in-person at Boston, MA, between November 13th- 15th. Through this event, fellow researchers and scientists from over 100 countries will have an opportunity to share their study findings. Date of Event: 2021. 11. 13 - 15

2021-04-20

The 37th Annual Meeting of KSOT/KEMS

The 37th Annual Meeting of KSOT/KEMS NEXEL will attend KSOT/KEMS 2021 to introduce our products and service to other participants and attendees. The 37th regular academic conference in this fall has prepared a variety of international academic events under the theme of “Innovative Approaches for Human Safety and Health,” so that members of the society and the fields related to toxicology invite you. Come visit us at Booth #3 Date of Event: 2021. 11. 01 - 02

2021-11-23

KSSCR 2021 Annual Meeting

Topic: Application of stem cells in toxicology August 13, 2021 Fri, 15:00 ~ 17:00 Evaluation of Cardiac Safety Using Human Pluripotent Stem Cell-derived Cardiomyocytes Venue: BEXCO, Busan We are pleased to announce that Dong-Hun Woo, Chief Operating & Technology Officer at NEXEL Co., Ltd. is presenting "Evaluation of Cardiac Safety Using Human Pluripotent Stem Cell-derived Cardiomyocytes" in the "Session 8: Application of stem cells in toxicology" at KSSCR 2021 Annual Meeting. Title: Evaluation of Cardiac Safety Using Human Pluripotent Stem Cell-derived Cardiomyocytes Speaker: Dong-Hun Woo, Ph.D. / Chief Operating & Technology Officer at NEXEL Co., Ltd. Time&Date: 15:00 ~ 17:00, Friday, August 13 2021 Click here for more. Date of Event: 2021. 8. 13

2021-08-17

CONTACT
Contact Information
- Address: 8F, 55 Magokdong-ro, Gangseo-gu, Seoul, Republic of Korea(07802)
- Business Registration No.: 109-86-37282
- CEO: Choongseong Han
- Tel: +82-2-2088-8886
- Fax: +82-2-2088-8884
- E-mail: support@nexel.co.kr